(Foxx Life Sciences: Hyderabad, India) -- Foxx Life Sciences announced the successful completion of its open house event, held at the company’s facility in Hyderabad, India. The event was well attended by industry leaders, partners, and community members, marking a significant milestone in Foxx Life Sciences’ ongoing commitment to innovation and excellence in the life sciences sector.

Foxx celebrated five years of bioprocess manufacturing in India, and the inauguration of two new manufacturing plants, including a new state-of-the-art blow- and injection-molding facility spread across 40,000 sq. ft. Guests had the chance to interact with the company’s experts, explore the latest advancements in manufacturing, and discover Foxx Life Sciences’ innovative solutions.

“We are thrilled with the turnout and the positive feedback from our open house event. This event underscores our dedication to fostering innovation and collaboration in India within the life sciences community,” says Thomas Taylor, founder and CEO of Foxx Life Sciences.

Eknath Kulkarni, co-founder, part owner, and president of Foxx Life Sciences APAC, says, ”We are excited to continue building strong relationships with our customers, suppliers, and employees with these new major investments. From R&D, prototyping, machining, welding, injection molding, clean room assembly, and Asia logistics, Foxx is ready to support our global customers.”

Rick Schwartz, president of Foxx Life Sciences, also attended the event. He says, “The open house was a fantastic opportunity to showcase our capabilities and share our vision for the future. We are committed to driving growth and excellence in the industry, and events like this help us connect with the community and highlight our contributions.”

The two new plants in Hyderabad further strengthen Foxx Life Sciences’ global positioning and enhance its manufacturing redundancies, ensuring robust and reliable operations across multiple locations. Manufacturing redundancy is critical for vaccine, biotech, pharma, and medical end users. With a focus on quality (ISO 13485 since 2010), seven certified ISO Class 7 clean rooms, and five manufacturing plants, Foxx is the perfect partner for any life sciences disposable product or bioprocess single-use custom assembly.